ClinicalTrials.Veeva

Menu

Impact of Sevoflurane Versus Propofol on Postoperative Delirium in Elderly Diabetic Patients Undergoing Non-Cardiac Surgery: a Multicenter, Randomized Controlled Trial

A

Air Force Military Medical University of People's Liberation Army

Status

Enrolling

Conditions

Postoperative Delirium (POD)
Diabetes

Treatments

Drug: TIVA ( anesthesia with propofol and remifentanil)
Drug: VA(anesthesia with sevoflurane and remifentanil)

Study type

Interventional

Funder types

Other

Identifiers

NCT06788743
NCT06788743

Details and patient eligibility

About

The present study is a multicenter, randomized controlled clinical trial, which plans to enroll 450 diabetic patients aged more than 60 years. The participants will be randomly assigned in a 1:1 ratio and will receive either propofol or sevoflurane for intraoperative anesthesia maintenance to evaluate the impact of these two anesthetic drugs on postoperative delirium. The aim of our study is to explore whether the use of propofol for anesthesia maintenance in elderly diabetic patients undergoing elective non-cardiac major surgery can reduce the incidence of postoperative delirium. This study will provide new perspectives for improving perioperative management in elderly diabetic patients and optimizing anesthesia management strategies to reduce the risk of postoperative delirium.

Enrollment

450 estimated patients

Sex

All

Ages

60+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥60 years
  • Elective surgery (with an expected duration of 2 hours or more)
  • ASA grade Ⅰ-Ⅲ
  • Voluntary participation and informed consent obtained
  • Diabetes mellitus

Exclusion criteria

  • Known neurological or psychiatric diseases (Parkinson's disease, depression, schizophrenia), or cognitive impairment (dementia)
  • Severe visual or auditory impairments, language barriers, or patients who cannot cooperate
  • Long-term use of sedatives, antipsychotic drugs, or long-term alcohol abuse
  • Neurosurgical patients
  • Patients who are expected to require hepatic portal blockage during surgery
  • Patients who are expected to be transferred to ICU after surgery
  • Patients with a known allergy to the drugs used in this study or those suspected of having propofol infusion syndrome

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

450 participants in 2 patient groups

TIVA
Experimental group
Description:
Participants assigned to the TIVA group will receive propofol combined with remifentanil for anesthesia maintenance during the surgery
Treatment:
Drug: TIVA ( anesthesia with propofol and remifentanil)
VA
Experimental group
Description:
Participants assigned to the VA group will receive sevoflurane combined with remifentanil for anesthesia maintenance during the surgery.
Treatment:
Drug: VA(anesthesia with sevoflurane and remifentanil)

Trial contacts and locations

1

Loading...

Central trial contact

Huang Nie

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems